Home > Insider Trading > Filing (0001209191-21-021320)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1422143	Kura Oncology Inc.	KURA	Pharmaceutical Preparations (2834)	611547851

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1785406	Kathleen Ford	C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-03-15	6,250	$19.43	6,250	No	4	M	Direct
Common Stock	Disposition	2021-03-15	6,250	$29.43	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to purchase common stock	Disposition	2021-03-15	6,250	$0.00	6,250	$19.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
215,625		2029-08-08	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020.
This transaction was executed in multiple trades at prices ranging from $29.43 to $29.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option vests in 48 equal monthly installments commencing on August 9, 2019.